Control group | Patient group | ||||
---|---|---|---|---|---|
HPV 16 group | HPV 18 group | ||||
Alleles | n (%) | n (%) | OR(95% CI) | n (%) | OR(95% CI) |
14 bp In/Del | |||||
In | 108(29.2) | 83(31.9) | 1.14(0.81–1.60) | 100(38.5) | 1.52(1.08–2.12) a |
Del | 262(70.8) | 177(68.1) | 0.88(0.62–1.24) | 160(61.5) | 0.66(0.47–0.92) a |
n | 370 | 260 | 260 | ||
+3142 C/G | |||||
C | 159(43.0) | 109(41.9) | 0.96(0.69–1.32) | 71(27.3) | 0.50(0.36–0.70) b |
G | 211(57.0) | 151(58.1) | 1.04(0.75–1.44) | 189(72.7) | 2.01(1.43–2.82) b |
n | 370 | 260 | 260 | ||
Genotypes | |||||
14 bp In/Del | |||||
In/In | 13(7.0) | 13(10.0) | 1.47(0.66–3.28) | 16(12.3) | 1.86(0.87–3.98) |
In/Del | 82 (44.3) | 57(43.8) | 0.98(0.62–1.54) | 68(52.3) | 1.38(0.88–2.16) |
Del/Del | 90(48.7) | 60(46.2) | 0.90(0.57–1.42) | 46(35.4) | 0.58(0.36–0.92) c |
n | 185 | 130 | 130 | ||
+3142 C/G | |||||
C/C | 39(21.1) | 25(19.2) | 0.89(0.51–1.56) | 8(6.2) | 0.25(0.12–0.52) d |
C/G | 81(43.8) | 59(45.4) | 1.07(0.68–1.68) | 55(42.3) | 0.94(0.60–1.48) |
G/G | 65(35.1) | 46(35.4) | 1.01(0.63–1.62) | 67(51.5) | 1.96(1.24–3.10) e |
n | 185 | 130 | 130 | ||
Haplotypes | |||||
In/G | 108(29.2) | 83(31.9) | 1.14(0.81–1.60) | 100(38.5) | 1.52(1.08–2.12) f |
Del/G | 103(27.8) | 68(26.2) | 0.92(0.64–1.31) | 89(34.2) | 1.35(0.96–1.90) |
Del/C | 159(43.0) | 109(41.9) | 0.96(0.69–1.32) | 71(27.3) | 0.50(0.35–0.70) g |
n | 370 | 260 | 260 |